Replimune Group, Inc.REPLNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+20.9%
5Y CAGR+31.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+20.9%/yr
vs +54.6%/yr prior
5Y CAGR
+31.2%/yr
Recent deceleration
Acceleration
-33.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.9x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $223.39M | +17.9% |
| 2025 | $189.45M | +8.3% |
| 2024 | $174.96M | +38.3% |
| 2023 | $126.53M | +56.9% |
| 2022 | $80.64M | +40.3% |
| 2021 | $57.49M | +48.3% |
| 2020 | $38.76M | +74.8% |
| 2019 | $22.17M | +64.1% |
| 2018 | $13.52M | +94.9% |
| 2017 | $6.94M | - |